Related Experiment Video
Updated: Sep 14, 2025
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Trends and Future Projections of Vitreoretinal Surgery in a Tertiary Hospital in China (2005-2022)
Chin-Ling Tsai1,2, Baoyi Liu1,2, Yaping Liu1,2
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou Provincial Key Laboratory of Ophthalmology Visual Science, Guangzhou, 510060, People's Republic of China.
Purpose:
To analyze past trends and project future trajectories of vitreoretinal surgery in China.
Methods:
A single-institution, retrospective analysis of vitreoretinal surgeries conducted at Zhongshan ophthalmic center (ZOC), Sun Yat-sen University, from 2005 to 2022, utilizing ZOC's inpatient database. Patients hospitalized in the retinal surgery department were included. The number of surgeries was stratified by final diagnosis, and a time series forecasting model was employed to predict the number of patients undergoing vitreoretinal surgery up to and including the year 2032.
Results:
The number of patients undergoing vitreoretinal surgery increased nearly fourfold from 2005 to 2022, reaching a total of 5600 vitreoretinal surgeries in 2022. The majority of indication was given for the treatment was rhegmatogenous retinal detachment (RRD). Among the diagnosis categories, macular diseases (MD) increased by 15.61%, and diabetic retinopathy (DR) by 11.99% during the study period. Vitreoretinal surgeries are projected to increased annually, with an estimated 9231 vitreoretinal surgeries by 2032.
Conclusion:
The demand for vitreoretinal surgery in China has grown substantially over the last decade and is anticipated to rise further. Healthcare systems must adapt to accommodate the high demand.
